The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver Disease
NCT00819338
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
58
Enrollment
OTHER
Sponsor class
Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT:
Efamax
Sponsor
University of Nottingham